These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2106408)

  • 1. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators.
    Chest; 1990 Mar; 97(3):528-33. PubMed ID: 2106408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
    Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
    Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
    Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
    J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
    Goldhaber SZ; Agnelli G; Levine MN
    Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.
    Verstraete M; Miller GA; Bounameaux H; Charbonnier B; Colle JP; Lecorf G; Marbet GA; Mombaerts P; Olsson CG
    Circulation; 1988 Feb; 77(2):353-60. PubMed ID: 3123091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism.
    Diehl JL; Meyer G; Igual J; Collignon MA; Giselbrecht M; Even P; Sors H
    Am J Cardiol; 1992 Dec; 70(18):1477-80. PubMed ID: 1442621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.
    Goldhaber SZ; Meyerovitz MF; Green D; Vogelzang RL; Citrin P; Heit J; Sobel M; Wheeler HB; Plante D; Kim H
    Am J Med; 1990 Mar; 88(3):235-40. PubMed ID: 2106783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.
    Goldhaber SZ; Kessler CM; Heit J; Markis J; Sharma GV; Dawley D; Nagel JS; Meyerovitz M; Kim D; Vaughan DE
    Lancet; 1988 Aug; 2(8606):293-8. PubMed ID: 2899718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.
    Dalla-Volta S; Palla A; Santolicandro A; Giuntini C; Pengo V; Visioli O; Zonzin P; Zanuttini D; Barbaresi F; Agnelli G
    J Am Coll Cardiol; 1992 Sep; 20(3):520-6. PubMed ID: 1512328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
    Goldhaber SZ; Haire WD; Feldstein ML; Miller M; Toltzis R; Smith JL; Taveira da Silva AM; Come PC; Lee RT; Parker JA
    Lancet; 1993 Feb; 341(8844):507-11. PubMed ID: 8094768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.
    Kucher N; Boekstegers P; Müller OJ; Kupatt C; Beyer-Westendorf J; Heitzer T; Tebbe U; Horstkotte J; Müller R; Blessing E; Greif M; Lange P; Hoffmann RT; Werth S; Barmeyer A; Härtel D; Grünwald H; Empen K; Baumgartner I
    Circulation; 2014 Jan; 129(4):479-86. PubMed ID: 24226805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
    Wang C; Zhai Z; Yang Y; Wu Q; Cheng Z; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH;
    Chest; 2010 Feb; 137(2):254-62. PubMed ID: 19741062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator.
    Come PC; Kim D; Parker JA; Goldhaber SZ; Braunwald E; Markis JE
    J Am Coll Cardiol; 1987 Nov; 10(5):971-8. PubMed ID: 2959713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.
    Mori E; Yoneda Y; Tabuchi M; Yoshida T; Ohkawa S; Ohsumi Y; Kitano K; Tsutsumi A; Yamadori A
    Neurology; 1992 May; 42(5):976-82. PubMed ID: 1579252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning.
    Parker JA; Markis JE; Palla A; Goldhaber SZ; Royal HD; Tumeh S; Kim D; Rustgi AK; Holman BL; Kolodny GM
    Radiology; 1988 Feb; 166(2):441-5. PubMed ID: 3122266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of pulmonary embolism: effect of therapy and putative age of emboli.
    Palla A; Pazzagli M; Manganelli D; De Nitto P; Marini C; Rossi G; Mazzantini D; Giuntini C
    Respiration; 1997; 64(1):50-3. PubMed ID: 9044475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics.
    Prewitt RM; Shiffman F; Greenberg D; Cook R; Ducas J
    Circulation; 1989 Apr; 79(4):929-38. PubMed ID: 2494007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute pulmonary embolism treated with tissue plasminogen activator.
    Goldhaber SZ; Vaughan DE; Markis JE; Selwyn AP; Meyerovitz MF; Loscalzo J; Kim DS; Kessler CM; Dawley DL; Sharma GV
    Lancet; 1986 Oct; 2(8512):886-9. PubMed ID: 2876327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.